Crispr Therapeutics shares owned by Intellectus Partners
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Intellectus Partners
from 13F filings
Historical chart of Intellectus Partners investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Intellectus Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Intellectus Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $545k | 8.0k | 68.16 |
| 2023-12-31 | $545k | 8.7k | 62.60 |
| 2023-09-30 | $388k | 8.6k | 45.39 |
| 2023-06-30 | $444k | 7.9k | 56.14 |
| 2023-03-31 | $355k | 7.9k | 45.23 |
| 2022-12-31 | $311k | 7.7k | 40.65 |
| 2022-09-30 | $524k | 8.0k | 65.34 |
| 2022-06-30 | $537k | 8.8k | 60.75 |
| 2022-03-31 | $621k | 9.9k | 62.79 |
| 2021-12-31 | $825k | 11k | 75.76 |
| 2021-09-30 | $1.3M | 11k | 111.91 |
| 2021-06-30 | $1.8M | 11k | 161.88 |
| 2021-03-31 | $1.2M | 10k | 121.83 |
| 2020-12-31 | $1.4k | 1.1k | 1.24 |
| 2020-09-30 | $790k | 9.4k | 83.64 |
| 2020-06-30 | $667k | 9.1k | 73.50 |
| 2020-03-31 | $384k | 9.0k | 42.45 |
| 2019-12-31 | $409k | 6.7k | 60.86 |
| 2019-03-31 | $48k | 1.4k | 35.56 |
| 2018-12-31 | $14k | 500 | 28.00 |
| 2018-09-30 | $22k | 500 | 44.00 |
| 2018-06-30 | $38k | 650 | 58.46 |
| 2017-06-30 | $7.0k | 425 | 16.47 |
| 2017-03-31 | $9.0k | 425 | 21.18 |
| 2016-12-31 | $7.0k | 325 | 21.54 |